GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diagnosticos da America SA (BSP:DASA3) » Definitions » Valuation Rank

Diagnosticos da America (BSP:DASA3) Valuation Rank


View and export this data going back to 2004. Start your Free Trial

What is Diagnosticos da America Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Diagnosticos da America Valuation Rank Related Terms

Thank you for viewing the detailed overview of Diagnosticos da America's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnosticos da America (BSP:DASA3) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).